The persisting puzzle of racial disparity in triple negative breast cancer looking through a new lens

10.2741/s527 ◽  
2019 ◽  
Vol 11 (1) ◽  
pp. 75-88 ◽  
Author(s):  
Ritu Aneja
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Racial Disparity ◽  
Triple Negative

Abstract PS7-86: Molecular determinants of racial disparity guide triple-therapy for triple negative breast cancer

2021 ◽  
Author(s):  
Sumit Siddharth ◽  
Sheetal Parida ◽  
Nethaji Muniraj ◽  
Shawn M Hercules ◽  
Arumugam Nagalingam ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Therapy ◽  
Triple Negative Breast Cancer ◽  
Racial Disparity ◽  
Triple Negative ◽  
Molecular Determinants

Abstract B082: Association of CXCR6/CXCL16 axis in triple-negative breast cancer and racial disparity

2020 ◽  
Author(s):  
Hina Mir ◽  
Jeronay K Thomas ◽  
Neeraj Kapur ◽  
Anita T Johnson ◽  
Shailesh Singh
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Racial Disparity ◽  
Triple Negative

scholarly journals Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants

Cancers ◽  
2018 ◽  
Vol 10 (12) ◽  
pp. 514 ◽  
Author(s):  
Sumit Siddharth ◽  
Dipali Sharma
Keyword(s):  
Breast Cancer ◽  
African American ◽  
Socioeconomic Factors ◽  
African American Women ◽  
Triple Negative Breast Cancer ◽  
Racial Disparity ◽  
Triple Negative ◽  
Oncogenic Pathways ◽  
Aggressive Tumor ◽  
Characteristic Features

Triple negative breast cancer (TNBC) is a molecularly heterogeneous disease whose incidence is disproportionately higher in African American (AA) women compared to European American (EA) women. Earlier onset, more advanced stage at diagnosis, and aggressive tumor phenotype are some of the characteristic features of TNBC in women with African ethnicity in comparison to EA women, denoting one of the most significant examples of racial disparity in oncology. It is still contentious whether health disparities result in aggressive behavior of TNBC in AA women or it is indeed a molecularly distinct disease. Given the “gaps-in-knowledge” surrounding racial disparity in TNBC, this review discusses various socioeconomic factors and the genetic predispositions contributing to poor prognosis of TNBC in AA women. While socioeconomic factors may contribute to poorer survival, multiple preclinical and clinical studies suggest inherent genetic risk factors and aberrant activation of oncogenic pathways in AA TNBC. Additionally, AA women are more likely to be obese and obesity is known to drive a molecular circuitry resulting in aggressive tumor progression indicating a potential obesity-TNBC axis at work in AA women. Given the multifactorial nature of AA TNBC, a transdisciplinary approach may help bridge the disparity that exists between AA and EA TNBC.

scholarly journals Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

eLife ◽  
2021 ◽  
Vol 10 ◽  
Author(s):  
Sumit Siddharth ◽  
Sheetal Parida ◽  
Nethaji Muniraj ◽  
Shawn Hercules ◽  
David Lim ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Progression ◽  
Triple Negative Breast Cancer ◽  
Racial Disparity ◽  
Triple Negative ◽  
Tumor Regression ◽  
Meta Analysis ◽  
Combined Treatment ◽  
Sequencing Data ◽  
Triple Combination Therapy

Mortality from triple negative breast cancer (TNBC) is significantly higher in African American (AA) women compared to White American (WA) women emphasizing ethnicity as a major risk factor; however, the molecular determinants that drive aggressive progression of AA-TNBC remain elusive. Here, we demonstrate for the first time that AA-TNBC cells are inherently aggressive, exhibiting elevated growth, migration, and cancer stem-like phenotype compared to WA-TNBC cells. Meta-analysis of RNA-sequencing data of multiple AA- and WA-TNBC cell lines shows enrichment of GLI1 and Notch1 pathways in AA-TNBC cells. Enrichment of GLI1 and Notch1 pathway genes was observed in AA-TNBC. In line with this observation, analysis of TCGA dataset reveals a positive correlation between GLI1 and Notch1 in AA-TNBC and a negative correlation in WA-TNBC. Increased nuclear localization and interaction between GLI1 and Notch1 is observed in AA-TNBC cells. Of importance, inhibition of GLI1 and Notch1 synergistically improves the efficacy of chemotherapy in AA-TNBC cells. Combined treatment of AA-TNBC-derived tumors with GANT61, DAPT, and doxorubicin/carboplatin results in significant tumor regression, and tumor-dissociated cells show mitigated migration, invasion, mammosphere formation, and CD44+/CD24- population. Indeed, secondary tumors derived from triple-therapy-treated AA-TNBC tumors show diminished stem-like phenotype. Finally, we show that TNBC tumors from AA women express significantly higher level of GLI1 and Notch1 expression in comparison to TNBC tumors from WA women. This work sheds light on the racial disparity in TNBC, implicates the GLI1 and Notch1 axis as its functional mediators, and proposes a triple-combination therapy that can prove beneficial for AA-TNBC.

Identification of new therapeutic leads for triple negative breast cancer subtypes

Planta Medica ◽  
2015 ◽  
Vol 81 (11) ◽  
Author(s):  
AJ Robles ◽  
L Du ◽  
S Cai ◽  
RH Cichewicz ◽  
SL Mooberry
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Breast Cancer Subtypes ◽  
Cancer Subtypes ◽  
Therapeutic Leads
Sign in / Sign up

Export Citation Format

Share Document